Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2018

Peli1 facilitates virus replication and promotes neuroinflammation
during West Nile virus infection
Lauren L. Vollmer
Washington University School of Medicine in St. Louis

Robyn S. Klein
Washington University School of Medicine in St. Louis

et al

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Vollmer, Lauren L.; Klein, Robyn S.; and et al, ,"Peli1 facilitates virus replication and promotes
neuroinflammation during West Nile virus infection." The Journal of Clinical Investigation. 128,11.
4980-4991. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7309

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Peli1 facilitates virus replication and promotes
neuroinflammation during West Nile virus
infection
Huanle Luo, … , Patricia V. Aguilar, Tian Wang
J Clin Invest. 2018;128(11):4980-4991. https://doi.org/10.1172/JCI99902.
Research Article

Inflammation

Virology

The E3 ubiquitin ligase Pellino 1 (Peli1) is a microglia-specific mediator of autoimmune
encephalomyelitis. Its role in neurotropic flavivirus infection is largely unknown. Here, we
report that mice deficient in Peli1 (Peli1–/–) were more resistant to lethal West Nile virus
(WNV) infection and exhibited reduced viral loads in tissues and attenuated brain
inflammation. Peli1 mediates chemokine and proinflammatory cytokine production in
microglia and promotes T cell and macrophage infiltration into the CNS. Unexpectedly,
Peli1 was required for WNV entry and replication in mouse macrophages and mouse and
human neurons and microglia. It was also highly expressed on WNV-infected neurons and
adjacent inflammatory cells from postmortem patients who died of acute WNV encephalitis.
WNV passaged in Peli1–/– macrophages or neurons induced a lower viral load and
impaired activation in WT microglia and thereby reduced lethality in mice. Smaducin-6,
which blocks interactions between Peli1 and IRAK1, RIP1, and IKKe, did not inhibit WNVtriggered microglia activation. Collectively, our findings suggest a nonimmune regulatory
role for Peli1 in promoting microglia activation during WNV infection and identify a
potentially novel host factor for flavivirus cell entry and replication.
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The E3 ubiquitin ligase Pellino 1 (Peli1) is a microglia-specific mediator of autoimmune encephalomyelitis. Its role in
neurotropic flavivirus infection is largely unknown. Here, we report that mice deficient in Peli1 (Peli1–/–) were more resistant
to lethal West Nile virus (WNV) infection and exhibited reduced viral loads in tissues and attenuated brain inflammation.
Peli1 mediates chemokine and proinflammatory cytokine production in microglia and promotes T cell and macrophage
infiltration into the CNS. Unexpectedly, Peli1 was required for WNV entry and replication in mouse macrophages and mouse
and human neurons and microglia. It was also highly expressed on WNV-infected neurons and adjacent inflammatory cells
from postmortem patients who died of acute WNV encephalitis. WNV passaged in Peli1–/– macrophages or neurons induced
a lower viral load and impaired activation in WT microglia and thereby reduced lethality in mice. Smaducin-6, which blocks
interactions between Peli1 and IRAK1, RIP1, and IKKε, did not inhibit WNV-triggered microglia activation. Collectively, our
findings suggest a nonimmune regulatory role for Peli1 in promoting microglia activation during WNV infection and identify a
potentially novel host factor for flavivirus cell entry and replication.

Introduction

Pellino 1 (Peli1), an E3 ubiquitin ligase, is an important regulator
in innate and adaptive immunity. It is essential for NF-κB activation induced by TIR domain–containing, adapter-inducing
IFN-β/TLR–mediated (TRIF/TLR) signaling in innate immune
cells such as macrophages and DCs (1). In microglial cells, in
which Peli1 is predominantly expressed in the brain, Peli1 regulates TLR/MyD88 signaling by promoting the degradation of
TNF receptor-associated factor 3 (Traf3), a process which leads
to microglia activation during the course of induction of experimental autoimmune encephalomyelitis (EAE) (2). Peli1 is also
implicated in the regulation of adaptive immune cell functions.
For example, it is a critical factor in the maintenance of peripheral T cell tolerance by regulating c-Rel via its K48 ubiquitination (3). Peli1 upregulation also plays a role in B cell lymphoma
tumorigenesis (4).
West Nile virus (WNV), a mosquito-borne, single-stranded
flavivirus that caused outbreaks in Asia, Europe, and Australia, has
been the leading cause of viral encephalitis in the United States
for more than a decade (5, 6). The features of acute illness range
from WN fever to neuroinvasive conditions, including meningitis,
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encephalitis, acute flaccid paralysis, and death (7). In addition, up
to 50% of convalescent WNV patients have been reported to have
long-term neurological sequelae or chronic kidney disease (8–16).
Currently, there is no specific therapeutic agent for the treatment
of WNV infection, and an approved vaccine is not available for
humans. Studies in animal models suggest that WNV-induced
CNS disease is caused by neuronal degeneration, a direct result
of viral infection, and/or by bystander damage from the immune
response to the pathogen in the CNS (17, 18) that is induced by
infiltrating inflammatory cells and CNS-resident cells, including
microglia/macrophages, neutrophils, and lymphocytes (19–23).
Microglial cells, the resident macrophages of the CNS that express
various pattern recognition receptors (PRRs), become activated
and produce innate proinflammatory molecules upon encountering microbial infection. Microglia activation in the CNS is the
hallmark of acute WNV infection (24, 25). It was also shown to
drive neuronal and synaptic loss, which together contributes to
memory impairment in WNV-induced chronic cognitive sequelae
(26). The underlying immune mechanisms of microglia activation
are not clearly understood. Here, we hypothesize that Peli1 mediates the activation of microglia and promotes neuroinflammation
during lethal WNV infection. Unexpectedly, we found that Peli1 is
required for WNV entry and replication in both peripheral myeloid
cells and CNS-resident cells. In particular, we found that defective
WNV replication in Peli1-deficient microglia and neurons directly
contributes to attenuated neuroinflammation in the CNS and ultimately decreases host susceptibility to lethal encephalitis.
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Figure 1. Peli1–/– mice are more resistant to lethal WNV infection. (A) Survival of WT and Peli1–/– mice after i.p. injection with WNV 385-99. n = 21 WT
mice; n = 23 and Peli1–/– mice. **P < 0.01 compared with the WT group (log-rank test). (B) Viremia was determined by FFA on days 2 and 3 p.i. Data are
presented as the mean ± SEM (n = 3–6) of samples collected from 1 representative experiment of 3 similar experiments. (C and D) Viral loads in the spleens
and brains of infected and noninfected (NF) mice were determined by qPCR. Data are presented as the mean ± SEM (n = 7–12) and were collected from 3
independent experiments. (B–D) *P < 0.05 and **P < 0.01 compared with the WT group (unpaired, 2-tailed Student’s t test). (E) Representative H&Estained images are of brains collected from 4 or 5 WNV-infected mice per group at the indicated time points. Scale bar: 25 μm. Original magnification, ×20.

Results

Peli1–/– mice are more resistant to systemic WNV infection. Peli1 promotes microglia-mediated brain inflammation in the course of
EAE induction (2). To investigate the role of Peli1 in WNV encephalitis, we infected WT and Peli1–/– mice i.p. with 100 focus-forming
units (FFU) of the WNV 385-99 strain and monitored them daily for survival (Figure 1A). Peli1–/– mice (39% survival) were more
resistant to WNV infection than were WT controls (9.5% survival).
To further understand the viral pathogenesis, we measured viral
burden in the peripheral organs and brain. Peli1–/– mice had lower
viremia on days 2 and 3 post infection (p.i.) and decreased splenic viral loads on day 6 compared with WT mice (Figure 1, B and
C). WNV crosses the blood-brain barrier (BBB) and infects the
CNS around day 3 in mice (25). Viral RNA levels in Peli1–/– mouse
brains were more than 15-fold lower than those of WT mice on
day 6 p.i. (Figure 1D). This trend continued but became insignificant by day 9, when both groups of mice started to succumb to
lethal WNV infection. On day 6 p.i., we noted meningitis (inflammation of the leptomeninge) in WT mice, but not in Peli1–/– mice
(Figure 1E). Inflammation further spread to the brain parenchyma
(encephalitis), as seen on day 9 in the striatum, hippocampus, and
cerebellum in both groups of mice. We found that encephalitis,
particularly perivascular cuffing and microglia activation (cells
with elongated nuclei), was much more extensive in the WT mice.

Thus, CNS inflammation started earlier and was more severe in
WNV-infected WT mice than in Peli1–/– mice. No histopathological differences were noted in naive mouse brains between the WT
and Peli1–/– groups (Supplemental Figure 1; supplemental material available online with this article; https://doi.org/10.1172/
JCI99902DS1).
Peli1–/– mice exhibit impaired innate cytokine production, but
modestly enhanced adaptive immune responses in the periphery. Peli1
is known to facilitate TRIF-dependent TLR signaling and proinflammatory cytokine production (1). Following WNV infection,
Peli1 expression was increased in the blood of WT mice (Supplemental Figure 2A). The RNA levels of IFN-α (Ifna) and IFN-β
(Ifnb) on day 6, IL-6 (Il6) and TNF-α (Tnfa) on days 3 and 6, and
Il12 on day 3 were all diminished in Peli1–/– mice (Supplemental
Figure 2B). Blood plasma protein levels of IL-1β and IL-10 were
also reduced in Peli1–/– mice (Supplemental Table 1), though no differences were noted in plasma IFN-γ or IL-17 levels between the
2 groups of mice. To study the adaptive immune responses in the
periphery, we first measured antibody production in the blood.
WNV-specific IgM responses were modestly enhanced in Peli1–/–
mice on days 3 and 9 p.i. (Supplemental Figure 2C). WNV-specific
IgG responses were similar between the 2 groups of mice (Supplemental Figure 2D). Peli1 is also known to negatively regulate T
cell signaling (3). We next collected splenic tissues from naive and
jci.org   Volume 128   Number 11   November 2018
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Figure 2. Peli1 facilitates WNV replication in macrophages and promotes high mortality in vivo. (A and B) The viral load of WNV-infected macrophages
was measured by qPCR (A) and FFA (B). Data are representative of 5 similar experiments and are presented as the mean ± SEM (n = 3–6). (C and D) Macrophages were infected with WNV for 1 hour at 4°C, washed, and then collected to measure intracellular viral RNA by qPCR in the attachment assay (C).
For virus entry (D), cells were subsequently resuspended in medium and incubated at 37°C. At the indicated time points, cells were washed to determine
intracellular viral RNA levels (n = 6). (E and F) Thin-section transmission electron micrographs of WNV-infected macrophages. (E) Viral particles were
observed at the plasma membrane at 0 minutes, in small, uncoated vesicles at 5 minutes, and in double-membrane vesicles at 10 hours. (F) Quantitation
of 10 fields of view of ultrathin sections. (G) Negative staining micrographs of WNV. Virions ranged in size from 41 nm to 47 nm and 23.5 nm to 39.5 nm
in supernatants of WT and Peli1–/– macrophages on day 4 p.i., respectively. (H) WT macrophages were infected at a MOI of 0.02 with viruses passaged in
WT (WTP) and Peli1–/– (Peli1–/–P) macrophages. The viral load was measured by FFA on day 4 p.i. Data are representative of 2 similar experiments and are
presented as the mean ± SEM (n = 4). Data in A–D and H were analyzed by unpaired, 2-tailed Student’s t test. *P < 0.05 and **P < 0.01 compared with the
WT group. (I) Survival rates of mice injected i.p. with 100 FFU WNV passaged in WT macrophages and Peli1–/– macrophages (n = 7–9). *P < 0.05 compared
with WT mice infected with WT macrophages (log-rank test).

WNV-infected WT and Peli1–/– mice. We found no necrosis in any
of the splenic sections examined. We noted a trend toward white
pulp expansion resulting from germinal center proliferation in WT
mice on days 3 and 6 p.i., but this returned to levels similar to those
in naive mice by day 9; in Peli1–/– mice, the expansion was continuously enhanced (Supplemental Figure 2, E and F). On day 7, both
CD4+ and CD8+ splenic T cells from Peli1–/– mice produced more
IFN-γ than did those from WT mice upon ex vivo restimulation
with WNV-specific peptides. CD4+ T cells from Peli1–/– mice also
induced higher levels of IL-6 and IL-10 production (Supplemental
Figure 2, G and H).
Peli1 is required for WNV entry and viral replication in macrophages and DCs, which further activates innate cytokine responses.
Macrophages and DCs are innate immune cells expressing many
4982
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PRRs, and both cell types are permissive to WNV infection in the
peripheral organs (27). To study Peli1-mediated innate immune
responses upon WNV infection, we first measured viral loads in
these 2 cell types by quantitative PCR (qPCR) and focus-forming assays (FFAs) and found that both viral RNA levels and viral
titers were significantly diminished in primary myeloid Peli1–/–
macrophages and DCs compared with WT controls (Figure 2, A
and B, and Supplemental Figure 3, A and B). We next performed
virus attachment and entry assays to determine Peli1 involvement in the WNV replication cycle. Macrophages from mice of
both groups were incubated with WNV (MOI = 3 or 10) at 4°C for
1 hour, allowing the virus to attach to the cell surface. After 1 hour
of incubation, the cells were washed to remove unattached virus,
and the amounts of viruses that had attached to the cell surface
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Figure 3. WNV-induced antiviral immune responses in WT and Peli1–/– macrophages. (A–F) WT and Peli1–/– macrophages were infected with WNV and
harvested at the indicated time points. (A) Peli1, Peli2, and Peli3 RNA levels in WT macrophages were measured on day 4 p.i. Data are representative of 3
similar experiments and are presented as the mean ± SEM (n = 3). ##P < 0.01 compared with the noninfected group (unpaired, 2-tailed Student’s t test).
(B–F) Cytokine RNA or protein levels were measured at the indicated time points by qPCR or Bio-Plex, respectively. Data represent the mean ± SEM of 5
to 10 samples collected from 2 independent experiments. *P < 0.05 and **P < 0.01 compared with the WT group. (G) WT macrophages were infected at a
MOI of 0.02 with WNV passaged in WT or Peli1–/– macrophages. On day 4 p.i., cytokine production was determined by qPCR. Data are presented as the fold
increase compared with mock-infected cells (mean ± SEM) and are representative of 2 similar experiments (n = 4 per group). *P < 0.05 compared with the
WTP group (unpaired, 2-tailed Student’s t test).

were measured by qPCR. We noted that Peli1–/– macrophages had
28% less virus attachment than did the WT cells (Figure 2C). Cells
were further incubated at 37°C to initiate viral entry. At 1.5 and 5
hours p.i., the infected cells were stringently washed to remove
free virus as well as cell-surface–associated virus, and intracellular viral RNA was quantified. As shown in Figure 2D, viral
RNA levels in Peli1–/– macrophages were 27% to 54% lower than
those in WT cells. These results indicated that Peli1 is involved
in WNV attachment and entry. To confirm these results, we performed ultrastructural analysis of macrophages from both groups
of mice 0 minutes, 5 minutes, and 10 hours after exposure to
WNV (Figure 2, E and F). At 0 hours, we detected 16 WNV particles, ranging from 41 to 46 nm in diameter, in association with
the plasma membrane in WT macrophages, whereas a total of 7
WNV particles were found in association with the plasma membrane of Peli1–/– macrophages. At 5 minutes p.i., we detected 38
viral particles with a diameter of approximately 42 nm in small,
uncoated vesicles of the WT macrophages. However, only 11 WNV
particles of the same size were identified in Peli1–/– macrophages.
By 10 hours, there were 55 WNV viral particles with a diameter of
42 nm inside the double-membrane vesicles of WT macrophages.
Interestingly, we found 18 viral particles of much smaller size (~25
nm) inside the double-membrane vesicles of Peli1–/– macrophages
(Figure 2, E and F). On day 4 p.i., viral particles detected in the
supernatants of WT macrophages ranged in diameter from 41 nm
to 47 nm, which are dimensions similar to those previously reported (28), whereas virions detected in the supernatant of Peli1–/–
macrophages showed substantial variations in size, ranging from
23.5 to 39.5 nm (Figure 2G). These observations suggest that Peli1
not only plays a role in initial cell attachment and entry, but also in
other aspects of the WNV life cycle within the host cells. We next

determined the infectivity of WNV that was passaged in WT or
Peli1–/– macrophages. WNV passaged in Peli1–/– macrophages had
a lower replication rate in WT macrophages compared with WNV
passaged in WT macrophages (Figure 2H). Furthermore, we challenged WT and Peli1–/– mice with 100 FFU WNV passaged in WT
or Peli1–/– macrophages. WT mice infected with WNV passaged in
Peli1–/– macrophages showed an increased survival rate (28.5%,
Figure 2I) compared with that of WT mice infected with WNV
passaged in WT cells (0%). Peli1–/– mice infected with WNV passaged either in WT macrophages (43%) or Peli1–/– cells (56%) also
showed a similar resistance to lethal WNV infection.
We next determined whether Peli1 mediates immune responses during WNV infection in macrophages and DCs. Following
WNV infection, we found that Peli1 expression was upregulated
in macrophages by day 4. In contrast, the other 2 Pellino family
members, including Peli2 and Peli3, remained at low levels (Figure
3A). Compared with WT cells, Peli1–/– macrophages had reduced
Ifna and Ifnb RNA levels on days 1 and 4 after WNV infection (Figure 3, B and C). Production of inflammatory cytokines, including IL-6 (Il6), TNF-α (Tnfa), and IL-12 (Il12), was also impaired
in Peli1–/– macrophages by day 4 (Figure 3, D–F). WNV infection
in Peli1–/– DCs also resulted in diminished levels of Ifnb, Il1b, and
Il12 compared with WT DCs (Supplemental Figure 3C). PRRs,
including TLR3 and TLR7, and retinoid acid–inducible gene I–like
receptors (RLR)s, such as retinoid acid–inducible gene I (RIG-I)
and melanoma differentiation antigen 5 (MDA-5), are involved
in WNV recognition and trigger the signaling cascade leading to
the production of type 1 IFNs and proinflammatory cytokines (25,
29–31). To understand the role of Peli1 in PRR-mediated signaling pathways, we treated WT and Peli1–/– macrophages with TLR
agonists (Poly I:C for TLR3, CL097 for TLR7, and Poly I:C LyoVec
jci.org   Volume 128   Number 11   November 2018
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Figure 4. Peli1 mediates neuroinflammation in the CNS after WNV infection. (A) RNA levels of Peli1 in the brains of WT mice following WNV infection
were determined by qPCR assay. Data are presented as the mean ± SEM of samples pooled from 2 to 3 independent experiments (n = 8). ##P < 0.01 compared with the noninfected group (unpaired, 2-tailed Student’s t test). (B–G) RNA levels of cytokines and chemokines in the brain at the indicated time
points were determined by qPCR assay. Data are presented as the mean ± SEM of 6 to 10 samples pooled from 2 independent experiments. (H–J) Brain
leukocyte infiltration following WNV infection. (H) The number of brain leukocytes is presented as the mean ± SEM of 9 to 10 mice from 2 independent
experiments, including naive microglial cells (NMGs), activated microglial cells (AMGs), macrophages (Mθs), and CD4+ and CD8+ T cells on day 9 p.i. (analyzed by flow cytometry). (I) Representative flow plot. (B–H) *P < 0.05 and **P < 0.01 compared with the WT group (unpaired, 2-tailed Student’s t test).
(J) Survival of WT and Peli1–/– mice after i.c. injection with WNV 385-99 (n = 9 per group). *P < 0.05 compared with the WT group (log-rank test).

for RLRs). We found that both Poly I:C and Poly I:C/LyoVec triggered lower Ifna, Ifnb, Il6, and Il12 expression levels in Peli1–/– macrophages. In contrast, stimulation with the TLR7 agonist induced
similar antiviral cytokine responses in both groups of macrophages
(Supplemental Figure 3, D–G). Peli1 is known to be dispensable
for MyD88-dependent TLRs but is required for TRIF-dependent
TLR signaling in macrophages and DCs (1). Consistent with the
previous findings, we demonstrate that Peli1 positively regulates
TLR3- and RLR-mediated, but not TLR7-mediated, innate cytokine responses in macrophages. Finally, to understand the effects
of defective viral replication on antiviral immunity, we infected
WT macrophages with the same dose of WNV passaged once in
WT or Peli1–/– macrophages. Interestingly, WNV passaged in Peli1–/–
cells triggered diminished Ifnb RNA and IL-6 protein levels in WT
macrophages compared with WNV passaged in WT macrophages.
4984
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The levels of reduction induced by WNV passaged in Peli1–/– cells
were similar to cytokine levels in Peli1–/– cells induced by WT virus
(Figure 3G and Supplemental Figure 3H). Collectively, these data
show that Peli1 positively mediates antiviral cytokine responses
mainly by a direct involvement in the WNV replication life cycle in
macrophages and DCs.
Peli1 is predominantly involved in CNS inflammation during
WNV infection. Peli1 was previously reported to be highly
expressed by neural tissues (2). Here, we noted that Peli1 expression was induced in the brain on days 6 and 9 p.i. (Figure 4A).
The mRNA levels of inflammatory cytokines including Il1b, Il6,
and Tnfa and chemokines such as Ccl2, Ccl7, and Cxcl10 were
decreased in Peli1–/– mice (Figure 4, B–G). Ifnb, but not Ifna, RNA
levels were also reduced in Peli1–/– mouse brains (Supplemental
Figure 4, A and B). To study the brain leukocyte phenotype, we
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Figure 5. WNV infection and induction of immune responses in microglia and neurons. (A) RNA levels of Peli1 in WT microglia on day 4 p.i. were
determined by qPCR. Data are presented as the mean ± SEM and are representative of 2 independent experiments (n = 5). ##P < 0.01 compared with the
noninfected group (unpaired, 2-tailed Student’s t test). (B–D) Primary microglia were infected with WNV 385-99 and harvested at the indicated time
points. Data are presented as the mean ± SEM of 4 to 8 pooled samples from 2 independent experiments. (B and C) Viral load was measured on day 4. (D)
Cytokine RNA levels were measured by qPCR at the indicated time points. (E–H) Primary mouse neurons were infected with WNV 385-99 and harvested at
the indicated time points. Data are presented as the mean ± SEM (n = 6 per group). (E) RNA levels of Peli1 in WT neurons on day 4 p.i. ##P < 0.01 compared
with the noninfected group (unpaired, 2-tailed Student’s t test). (F and G) Viral load was measured at the indicated time points by qPCR (F) and FFA (G.
(H) Il6, Ccl2, Ccl7, and Cxcl10 RNA levels were measured by qPCR at the indicated time points. (B–D and F–H) *P < 0.05 and **P < 0.01 compared with the
WT group (unpaired, 2-tailed Student’s t test).

performed flow cytometric analysis of these cells isolated on day
9 and found that the number and percentage of infiltrating CD4+
T cells, activated microglial cells (CD11bhiCD45lo), and macrophages (CD11bhiCD45hi) were decreased by up to 60% in Peli1–/–
mice (Figure 4, H and I, and Supplemental Figure 4C). To exclude
the effects of Peli1 on WNV infection in peripheral tissues, we
inoculated mice from both groups with WNV intracranially (i.c.)
(Figure 4J). Peli1–/– mice showed resistance that was similar to that
seen with systemic WNV infection (44% versus 11%, Peli1–/– versus WT). Collectively, these results indicate that Peli1 is involved
in WNV encephalitis predominantly by mediating CNS infection
and inducing neuroinflammation.
Peli1 promotes microglia activation via facilitation of WNV replication in neurons and microglia in mice and humans. Microglial cells are involved in CNS neuroinflammation (24, 32) and are
permissive to WNV infection (Supplemental Figure 5A). Peli1 is
highly expressed on microglial cells (2) and was enhanced following WNV infection, however, Peli2 and Peli3 remained at low
levels (Figure 5A and Supplemental Figure 5B). WNV triggered
higher mRNA levels of inflammatory cytokines (Tnfa and Il12) and
chemokines (Ccl2, Ccl4, and Cxcl10) in microglial cells (Supplemental Figure 5C). Interestingly, we observed that WNV infection
was nearly abolished in both Peli1–/– primary microglial cells (Figure 5, B and C) and Peli1-depleted microglial cells (Supplemental Figure 5D), which was accompanied by diminished levels of
inflammatory cytokines and chemokines (Figure 5D and Supplemental Figure 5E). Neurons are most permissive to WNV infection

in the CNS (18, 33). WNV infection upregulated Peli1 expression
on neurons by up to 200% (Figure 5E). WNV replication was also
significantly reduced in Peli1–/– neurons compared with that seen
in WT neurons (Figure 5, F and G). We found that mRNA levels of
chemokines (Ccl2, Ccl7, and Cxcl10) and inflammatory cytokines
(Il6 and Ifnb) were all diminished in WNV-infected Peli1–/– neurons by day 4 (Figure 5H and Supplemental Figure 5F). Western
blot analysis showed that phosphorylation levels of p38MAPK and
p65 were both reduced in WNV-infected Peli1–/– neurons on day 3
compared with levels in WT controls (Supplemental Figure 5, G
and H), which suggests a role of Peli1 in the positive regulation of
NF-κB and p38MAPK activation.
Immunostaining of postmortem hippocampal tissues from
patients who died of acute WNV encephalitis showed membrane
Peli1 on WNV-positive neurons and adjacent inflammatory cells,
but not in the same region of age-matched control patients (Figure
6A). Peli1 expression was also upregulated following in vitro WNV
infection in SHSY-5Y–differentiated neurons and HMC3 cells (a
human microglial cell line) (Figure 6, B and C) and WNV- infected
PBMCs (Supplemental Figure 6A). Nevertheless, its expression
was not changed in WNV-infected neural stem cell–derived neurons or in THP1-derived macrophages (Supplemental Figure 6A).
Knockdown (KD) of Peli1 expression in human microglial cells or
SHSY-5Y–differentiated neurons decreased viral loads by 20% to
35% by day 4 p.i. (Figure 6, D and E, and Supplemental Figure 6B).
Peli1 deficiency also decreased IL-6, CCL2, and CCL5 production
in human microglial cells (Figure 6, F–H). WNV infection did not
jci.org   Volume 128   Number 11   November 2018
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Figure 6. Peli1 expression and its role in human cells during WNV infection. (A) Immunodetection of Peli1 (green), WNV antigen (WNV Ag) (red), and
NeuN (purple), in postmortem hippocampal tissues from 1 control and 2 WNV-infected patients. Nuclei were counterstained with DAPI (blue). Scale bar: 8
μm. Insets are images of sections stained with isotype control antibodies or serum (original magnification, ×63). (B and C) RNA levels of Peli1 in SH-SY5–
derived neurons and human microglia on days 1 and 4 p.i. were determined by qPCR. Data are presented as the mean ± SEM and are representative of 2
similar experiments (n = 3–4). ##P < 0.01 compared with the noninfected group (unpaired, 2-tailed Student’s t test). (D–H) SHSY-5Y–derived neurons (D)
and human microglial cells (E–H) were treated with control or Peli1 siRNA (Peli1 KD), infected with WNV 385-99 at 48 hours, and harvested at the indicated
time points. (D and E) Viral load was measured on day 4 by qPCR. (F–H) IL-6, CCL-2, and CCL-5 production in microglial cells was measured on day 4 by BioPlex assay. Data are presented as the mean ± SEM and are representative of 2 similar experiments (n = 4). (D–H) *P < 0.05 and **P < 0.01 compared with
the control group (unpaired, 2-tailed Student’s t test).

induce inflammatory cytokine or chemokine production in human
neurons (data not shown). We noted that Peli1 KD (36% reduction,
Supplemental Figure 6C) in human fetal cortical neural stem cell–
derived (hNSC-derived) neurons led to a 30% decrease on Ifnb
levels on day 4 p.i. compared with levels in control siRNA–treated
neurons (Supplemental Figure 6D). These data suggest that Peli1
is involved in WNV replication in neural cells and induction of
inflammatory cytokines and chemokines in human microglial cells.
To determine whether defective replication contributes to
attenuated inflammatory responses in the CNS, we infected WT
microglial cells with WNV passaged in WT or Peli1–/– neurons or
macrophages. WT microglia infected with WNV grown in Peli1–/–
cells had lower viral titers (Figure 7, A and B) and reduced mRNA
levels of Il6, Ccl2, and Ccl7, but not of Tnfa or Cxcl10 (Figure
7, C–E), compared with cells infected with WNV grown in WT
cells. It is known that microglia respond to viral infection via
activation of p38MAPK (24). Microglia infected with WNV passaged in Peli1–/– cells also showed lower phosphorylation levels
of p38MAPK than did cells infected with WNV passaged in WT
neurons (Figure 7F). Smaducin-6, a membrane-tethered, palmitic acid–conjugated peptide composed of amino acids 422–441
of Smad6, was reported to interact with Peli1 and disrupt the
formation of IRAK1, RIP-1, and IKK, but not MAPK-mediated
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signaling complexes (34). Smaducin-6 treatment did not block
WNV infection or induction of inflammatory cytokine/chemokine production in microglial cells or macrophages, though it
decreased the levels of type 1 IFNs in macrophages (Figure 7, G
and H, and Supplemental Figure 7). Overall, our results suggest
that Peli1 is required for WNV replication in neural cells, which
promotes p38MAPK activation in microglia and induction of
inflammatory immune responses in the CNS.

Discussion

Peli1 has been reported to be an important mediator in the activation of NF-κB or p38MAPK in TLR-dependent signaling pathways
(2). In this study, we have provided evidence that Peli1 facilitates
WNV replication and mediates innate immunity in the periphery
and CNS (Figure 8). In particular, on the basis of several facts,
we conclude that Peli1 is predominantly involved in CNS neuroinflammation during WNV infection. First, although Peli1 promotes WNV replication in myeloid cells (macrophages and DCs),
it also positively regulates antiviral innate immune responses in
these cells, which compromise its overall pathogenic effects in the
periphery. Second, compared with myeloid cells, Peli1 expression
is highly enriched in CNS-resident cells and is even upregulated
following WNV infection. Third, Peli1 facilitates WNV replica-
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Figure 7. Peli1 promotes p38MAPK activation in microglia via facilitation of WNV replication. (A–F) BV2 cells were infected at a MOI of 0.02 with viruses
passaged in WT (WTP) and Peli1–/– (Peli1–/–P) macrophages or neurons. (A and B) On day 4 p.i., the viral load was measured by qPCR (A) or FFA (B). (C–E)
IL-6 and TNF-α production and Ccl2, Ccl7, and Cxcl10 RNA levels were measured on day 4 by Bio-Plex or qPCR, respectively. Data are presented as the mean
± SEM and are representative of 2 similar experiments (n = 4). (A–E) **P < 0.01 compared with the WT group (unpaired, 2-tailed Student’s t test). (F)
Western blot assay for p38MAPK activation. One representative sample of two per group is shown. (G and H) BV2 cells were infected at a MOI of 0.02 with
WNV 385-99 and treated with Smaducin-6 or control peptides 1 hour p.i. (G) Viral load was measured by qPCR on day 4 p.i. (H) Cytokine and chemokine
levels were measured on day 4 by qPCR. Data are presented as the fold increase compared with mock-infected cells (mean ± SEM) and represent 8 samples pooled from 2 independent experiments.

tion in microglia and neurons, especially in the latter, which are
the major cells infected during in vivo challenge. It also positively mediates NF-κB and/or p38MAPK activation in these cells and
boosts a robust production of inflammatory cytokines and chemokines, which attracts more inflammatory cells infiltrated from the
periphery and ultimately contributes to lethal WNV encephalitis. Thus, Peli1 synergistically promotes virus dissemination and
inflammation in the CNS. Last, Peli1–/– mice had similar levels of
resistance compared with WT mice following systemic and direct
intracranial WNV infection. This further indicates that Peli1 promotes WNV-induced pathology primarily in the CNS.
WNV-induced CNS disease is partially caused by bystander
damage from both the immune response induced in the CNS-residential cells (17, 18) and by infiltrating inflammatory cells (19–23).
As shown in Figure 4H, Peli1–/– mouse brains had a significantly
decreased number of infiltrating CD4+ T cells (P < 0.05), activated
microglia (P < 0.01), and macrophages (P < 0.01). Both CCL2 and
CCL7 are involved in monocytosis and monocyte accumulation in
the brain (35), whereas CXCL10 helps recruit antigen-specific T
cells (36). Microglial cells are the major producers of inflammatory cytokines and chemokines in the CNS following WNV infection
(25, 37). In vitro WNV infection in Peli1–/– or Peli1-depleted mouse
and human microglia resulted in a lower viral load and induced
impaired production of IL-6, CCL2, CCL7, and CXCL10. Neurons
are the primary targets during in vivo WNV replication in the CNS
(18, 38). WNV passaged in Peli1–/– neurons induced similarly lower
levels of p38MAPK phosphorylation in WT microglia, and this was
accompanied by impaired production of the chemokines CCL2
and CCL7, but not CXCL10, in these cells. Collectively, our results
suggest that Peli1 mediates proinflammatory cytokine and chemokine production predominantly via facilitation of WNV replication
in neural cells (microglia and neurons), which ultimately leads to
macrophage/monocyte and T cell infiltration into the CNS.

In line with findings of a previous report (37), we did not
note a significant induction of inflammatory cytokine responses in human neurons following WNV infection. Interestingly,
WNV induced higher Peli1 expression on mouse neurons than on
microglia. WNV-infected Peli1–/– mouse neurons had reduced levels of NF-κB and p38MAPK activation, accompanied by impaired
production of inflammatory cytokines and chemokines. We noted that noninfected Peli1–/– mouse neurons also had lower levels
p38MAPK activation, despite normal basal levels of cytokine production compared with WT controls (data not shown). Thus, it is
likely that Peli1 positively regulates inflammatory cytokine and
chemokine responses in WNV-infected mouse neurons via NF-κB
activation. Peli1 is known to activate NF-κB signaling via interaction with RIPK1, another RIPK family member, which was recently shown to mediate neuronal chemokine induction and recruit T
lymphocytes and inflammatory myeloid cells into the CNS (39).
Whether Peli1 interacts with RIPK3 and regulates inflammatory
responses remains to be investigated.
Smad6 and Smad7 are critical mediators for effective TGF-β1–
mediated suppression of IL-1R/TLR signaling via their simultaneous
binding to discrete regions of Peli1 (40). Smaducin-6, which is composed of amino acids 422–441 of Smad6, has been reported to disrupt
the formation of IRAK1-, RIP1-, and IKKε-mediated TRIF signaling
complexes, but not the phosphorylation of p38MAPK in macrophages
(34). We found that Smaducin-6 did not inhibit WNV replication
in microglia or macrophages. Further, Smaducin-6 did not block
the production of inflammatory cytokines or chemokines in WNVinfected microglia or macrophages. These results support a role of
Peli1 in the induction of inflammatory responses in both cell types
during WNV infection via the promotion of p38MAPK activation.
Consistent with the findings in myeloid and CNS-resident
cells, the production of type I IFNs, inflammatory cytokines,
and chemokines in the blood and CNS tissues were all impaired
jci.org   Volume 128   Number 11   November 2018
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Figure 8. Proposed model illustrating
how Peli1 promotes virus replication and neuroinflammation during
WNV infection. In the periphery, Peli1
promotes WNV replication in macrophages and DCs and positively regulates
antiviral innate immune responses in
these cells. Peli1 also negatively mediates IFN-γ production in T cells. Once
the virus crosses the BBB and enters the
CNS, Peli1 facilitates WNV replication
in microglia and neurons and further
boosts a robust inflammatory cytokine
and chemokine production in these
cells, which attracts more inflammatory
cells infiltrated from the periphery and
ultimately contributes to lethal WNV
encephalitis.

in WNV-infected Peli1–/– mice. Our results suggest a role of Peli1
as a positive regulator of innate immunity. There are conflicting
reports on the role of Peli1 in the induction of type I IFN responses during viral infection. For example, Xiao et al. found that Peli1
negatively regulates IFN signaling in microglia and macrophages
during vascular stomatitis viral infection in the CNS (41). Another group has shown that Peli1 interacts with DEAF1 and positively
regulates IFN-β production following Sendai virus infection (42).
While our results are in line with the latter finding, the main difference between ours and the previous findings is that Peli1 positively
mediates immune induction predominantly via the facilitation of
WNV entry and replication.
The WNV life cycle includes attachment/entry, translation,
RNA replication, and egress of viral particles. Although the virus
relies heavily on host proteins during its life cycle (43, 44), our
understanding of the molecular interactions of viruses and mammalian host cells and their effects on viral pathogenesis is limited.
Previous RNA interference screening of human genes responsible
for interaction with WNV proteins identified the Ub ligase CBLL1 as
being critical for WNV internalization during in vitro infection (45).
Several host factors, including AXL and TIM1, have been shown to
be involved in flavivirus replication from in vitro cell culture studies. However, their roles remain to be confirmed in vivo (46–48).
In this study, by using both in vivo and in vitro models, we identified Peli1 as a host factor required for WNV initial cell attachment
and entry, a process that further promotes TLR-mediated inflammatory responses in mouse and human neural cells. Interestingly,
the size of the virions generated after passaging WT WNV once in
Peli1–/– cells was markedly reduced. We noted no genetic changes
in the passaged viruses (data not shown). However, the reduction of virion size is likely due to an altered protein composition
or changes in the ratio of viral proteins in the virions during virus
assembly (49). In particular, the smaller viral particles produced
in Peli1–/– cells are consistent with the size of recombinant subviral
particles assembled in the endoplasmic reticulum during flavivirus
infection in mammalian cells reported previously (50). The subviral particles consist of the premembrane-E (prM-E) structural
proteins, retain functional properties, and are transported from the
endoplasmic reticulum through the secretory pathways to undergo
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cleavage maturation by the cellular protease furin. Mutation of the
furin recognition site of the prM of the tick-borne encephalitis virus
resulted in secretion of the smaller subviral particles. Altogether,
our data suggest that Peli1 is involved in WNV attachment, entry,
and assembly. The smaller virions generated from Peli1–/– cells had
reduced replication rates in WT cells and triggered attenuated
inflammatory responses in these cells, all of which contributed to
a higher resistance in WT mice. These results further support our
hypothesis that Peli1 mediates inflammatory responses and promotes WNV encephalitis by facilitating virus replication. Consistent with our findings in the mouse model, we also demonstrate
that Peli1 expression is associated with WNV infection and inflammatory cell activation in postmortem hippocampal tissues from
patients who died of acute WNV encephalitis. Results from this
study provide us with a better understanding of the mechanisms
by which WNV induces lethal encephalitis. We believe our findings
will ultimately help to identify new therapeutic targets such as Peli1
and lead to the development of virus replication inhibitors to prevent and treat WNV-induced encephalitis. Last, Peli1 is expressed
on many cell types and is highly enriched in CNS tissues. Future
studies will be needed to determine the role of Peli1 in other virus
models, in particular in neurotropic flavivirus models.

Methods

Further information can be found in the Supplemental Methods.
Mice. Five- to eight-week-old C57BL/6 (B6) mice were purchased
from The Jackson Laboratory. Peli1–/– mice (on a B6 background) (2,
51) were bred at UTMB. Both female and male mice were used in this
study and were age and sex matched. Mice were inoculated i.p. with
100 FFU WNV 385-99 (52, 53) or WNV 385-99 passaged once in WT
and Peli1–/– macrophages. In some experiments, mice were challenged
intracranially (i.c.) with 5 FFU WNV 385-99.
Cells. BM-derived DCs, macrophages, and primary microglia cultures were isolated as described previously (2, 54). Neurons were generated as described previously (55), with slight modifications. After the
dissection and dissociation of cortices of E18.5 mouse embryos, cells
were enriched using a Mouse Neuron Isolation Kit (Miltenyi Biotec)
and cultured for 5 days in neurobasal medium containing B-27 supplement (Invitrogen, Thermo Fisher Scientific). BV2 cells were provided
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by A. Cardona (University of Texas San Antonio, San Antonio, Texas,
USA). BM-DCs or macrophages, microglia, and BV2 cells were infected with WNV at a MOI of 0.1 or 0.02, and neurons were infected at
a MOI of 0.003. SH-SY5Y cells were cultured in F12K medium and
Eagle’s minimal essential media (EMEM) (Invitrogen, Thermo Fisher Scientific) and seeded in a 6-well plate for 1 day and then replaced
with fresh medium containing 30 μM retinoic acid (MilliporeSigma)
and 1% B-27 Supplements (Gibco, Thermo Fisher Scientific, catalog
17504) for 5 days, and the cells differentiated into neurons. Smaducin-6 or Pal-Scram peptides (34) were purchased from MilliporeSigma and used at 100 nm 1 hour after infection. Supernatants and cells
were harvested 24 and 96 hours p.i. to measure the viral load and cytokine production. In some experiments, WT and Peli1–/– macrophages
or neurons were infected with WNV 385-99. Culture supernatants
were then harvested on day 4 for virus titration by FFA. Equal titers of
viruses from WT and Peli1–/– culture were subsequently used for in vivo
and in vitro infection studies.
FFA. Vero cells were incubated with sample dilutions for 1 hour.
A semisolid overlay containing 0.8% methylcellulose (MilliporeSigma), 3% FBS, 1% penicillin-streptomycin, and 1% L-glutamine was
added. At 48 hours, the semisolid overlay was removed and cells were
washed and fixed with 1:1 of an acetone/methanol solution for at least
30 minutes at –20°C. Cells were next subjected to immunohistochemical staining with a rabbit WNV polyclonal antibody (World Reference
Center for Emerging Viruses and Arboviruses [WRCEVA], T35502)
followed by goat anti-rabbit HRP–conjugated IgG (KPL, 474-1516) for
1 hour. Next, cells were incubated with a peroxidase substrate (VECTOR Laboratories) until color developed. The number of foci was used
to calculate viral titers.
qPCR. Samples were resuspended in TRIzol (Invitrogen, Thermo
Fisher Scientific) for RNA extraction. cDNA was synthesized by using
a qScript cDNA Synthesis Kit (Bio-Rad). The sequences of the primer sets for WNV envelope (Wnve), Peli1, Peli2, and Peli3 and cytokine
cDNA and PCR reaction conditions were described previously (2, 25,
36, 53, 56). The assay was performed using the CFX96 Real-time PCR
System (Bio-Rad). Gene expression was calculated on the basis of Ct
values using the following formula: 2^ –[Ct(target gene)-Ct(GAPDH or ACTB)] (53).
Viral attachment and entry assays. BM-macrophages were incubated with WNV (MOI of 3 or 10) at 4°C for 1 hour, allowing the virus to
attach to the cell surface. After 1 hour of incubation, infected cells were
washed 3 times with cold PBS to remove unbound virions. Cell-surface–associated viruses were removed by washing with cold alkaline
high-salt solution (1 M NaCl and 50 mM sodium bicarbonate, pH 9.5).
After 2 cold PBS washes, cells were harvested and suspended in 3 ml
DMEM medium containing 2% FBS. Total cells were collected by centrifugation at 1,000 g for 5 minutes. The cell pellets were resuspended
in TRIzol for RNA extraction to measure viral titers by qPCR. Some
cells were further incubated at 37°C to initiate viral entry. At 1.5 and
5 hours p.i., the infected cells were stringently washed to remove free
virus as well as cell-surface–associated virus, and intracellular viral
RNA levels were quantified by qPCR.
Transmission electron microscopy. Cells were washed with ice-cold
PBS and incubated on ice for 15 minutes before exposure to WNV (MOI
= 10) for 1 hour. Cells were then rinsed with ice-cold PBS, resuspended
in prewarmed media, and incubated at 37°C. At 0 hours, 5 minutes,
and 10 hours p.i., cells were pelleted and fixed for at least 1 hour in
a mixture of 2.5% formaldehyde and 0.1% glutaraldehyde in 0.05
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M cacodylate buffer (pH 7.3), to which 0.01% picric acid and 0.03%
CaCl2 were added (electron microscopy [EM] fixative). The pellets
were washed in 0.1 M cacodylate buffer followed by postfixation in 1%
OsO4 in 0.1 M cacodylate buffer for 1 hour, washing, and then en bloc
staining with 2% aqueous uranyl acetate for 20 minutes at 60°C. The
pellets were next dehydrated in ethanol, processed through propylene
oxide, and embedded in Poly/Bed 812 (Polysciences). Sections were
cut on a Leica EM UC7 ultramicrotome, stained with lead citrate, and
examined with a Philips CM-100 transmission electron microscope
(TEM) at 60 kV. Images were acquired with a Gatan Orius SC200
digital camera. In some experiments, supernatants of WNV-infected
cells were concentrated on day 4 p.i. using 3-kDa spin columns (Sartorius). The concentrated supernatants were centrifuged for 10 minutes
at 3,000 g to remove debris. Next, nickel grids were incubated with
clarified supernatants for 10 minutes followed by glutaraldehyde fixation and 2% uranyl acetate staining. Micrographs were taken using a
CM100 TEM (Philips).
Flow cytometry. Brain leukocytes were isolated as described previously (20) and stained with antibodies for cell-surface markers,
including CD3 (eBioscience, clone 145-2C11); CD4 (eBioscience,
clone GK1.5); CD8 (eBioscience, clone 53-6.7); CD11b (eBioscience,
clone M1/70); Gr-1 (eBioscience, clone RB6-8C5); and CD45 (BD
Biosciences, clone 30-F11), fixed with 1% paraformaldehyde in PBS,
and examined with a C6 Flow Cytometer (BD Biosciences). Dead cells
were excluded on the basis of forward and side light scatter.
Western blot analysis. Protein was dissolved in 1× SDS loading buffer,
separated on SDS-PAGE gels, electroblotted onto nitrocellulose membranes, probed with primary and secondary antibodies, and detected
using a Pierce ECL System (Thermo Fisher Scientific). The primary antibodies against phosphorylated p38 (p-p38) (Thr180/Tyr182, no. 9211s),
p38 (no. 9212), p–NF-κB RelA (Ser 468, no. 3039), and NF-κB (no. 3034)
were from Cell Signaling Technology. Mouse monoclonal anti–β-actin
(MilliporeSigma, clone AC-15) was used as a loading control.
Histology. Mice were transcardially perfused with PBS. Brains
and spleens were removed and placed in 4% paraformaldehyde (PFA)
for 3 days at 4°C, followed by 70% ethanol before embedment in optimal cutting temperature compound. H&E staining was performed at
the Histopathology Laboratory Core of Baylor College of Medicine
(Houston, Texas, USA).
Immunohistochemistry. Paraffin-embedded human hippocampal
tissues were obtained from fatal WNV encephalitis cases (provided
by Beth Levy, St. Louis University, St. Louis, Missouri, USA) and from
control postmortem samples from patients without neurologic diseases. Sections were deparaffinized in xylene, rehydrated in serial dilutions of ethanol, and boiled in citrate buffer (pH 6.0) for 30 minutes
for antigen retrieval. Next, the sections were incubated for 2 hours at
room temperature in blocking solution (10% serum and 2% Tween-20
in PBS) to permeabilize and block nonspecific binding. This was followed by incubation with primary antibodies against Peli1 (Santa Cruz
Biotechnology, sc-271065, 1:50), WNV antigen (UTMB WRCEVA),
T35502, 1:500), and NeuN (MilliporeSigma, clone A60, 1:20) or isotype-matched IgG in PBS supplemented with10% serum overnight
at 4°C. After washing, the sections were incubated for 1 hour at room
temperature with fluorescently conjugated secondary antibodies (Life
Technologies, Thermo Fisher Scientific, 1:500). Autofluorescence was
darkened using 5% Sudan black B (diluted in 70% ethanol) incubated
for 10 minutes. After washing, nuclei were counterstained with DAPI,
jci.org   Volume 128   Number 11   November 2018
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and coverslips were applied with ProLong Gold Antifade Mountant
(Thermo Fisher Scientific). Immunofluorescence was captured using
a Zeiss LSM 510 laser-scanning confocal microscope.
Statistics. Survival curve comparisons were performed using
GraphPad Prism software, which uses the log-rank test. Values for
viral burden, cytokine production, and antibody and T cell response
experiments are presented as the mean ± SEM. P values for these
experiments were calculated with an unpaired, 2-tailed Student’s t
test. Statistical significance was accepted at a P value of less than 0.05.
Study approval. All experiments were performed in compliance
with and under the approval of the IACUC of UTMB.
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